When Disease Genes Were Survival Advantages

When Disease Genes Were Survival Advantages

Why does evolution allow genes that cause disease to persist in the population? This question has puzzled biologists for generations. The answer, revealed across many conditions, is that many genes we now associate with disease were powerfully protective in ancestral environments — and the environment changed faster than evolution could respond.

The Sickle Cell Example

The classic case is sickle cell anaemia. Carrying two copies of the sickle cell allele causes a serious, often fatal blood disorder. Logic might suggest this gene should disappear from the population. Why would natural selection maintain something so harmful?

Because carrying one copy of the allele provides significant protection against Plasmodium falciparum malaria. In sub-Saharan Africa, where malaria has been endemic for millennia, this protection was worth the cost. Populations in malaria-endemic regions carry the allele at much higher frequencies than populations from malaria-free regions — direct evidence of selective pressure.

The Thrifty Gene Hypothesis

James Neel’s “thrifty genotype” hypothesis proposes that genes promoting efficient fat storage — now associated with obesity and type 2 diabetes — were strongly advantageous in ancestral environments characterised by feast-famine cycles. Being able to rapidly store energy as fat during times of abundance, and metabolise it efficiently during scarcity, was survival-critical.

In a food-secure environment with constant caloric surplus and minimal physical expenditure, these same genes produce metabolic disease. The genes did not become harmful. The environment changed to make them harmful.

The Cystic Fibrosis Paradox

Cystic fibrosis (CF) is caused by mutations in the CFTR gene. It severely reduces lung and digestive function. Why has it persisted at relatively high frequencies in European populations? The leading hypothesis: CFTR mutations may reduce intestinal fluid secretion, providing protection against cholera and typhoid — which cause death through massive intestinal fluid loss. In environments where these infections were major causes of death, carrying the CFTR mutation may have been net advantageous.

Implications for How We Understand Chronic Disease

This evolutionary framing changes the moral character of chronic disease. The person with type 2 diabetes does not have a “broken” metabolism — they have an ancestrally-tuned metabolism in a mismatched environment. The person with an autoimmune condition does not have a “dysfunctional” immune system — they have an immune system that evolved in a microbial environment that no longer exists.

This reframing matters clinically. It shifts the focus from correcting individual pathology to understanding the environmental mismatch — and addresses what actually changed.

FAQ

If diseases are evolutionary trade-offs, does that mean we can’t prevent them?

Not at all. Understanding the mismatch points directly to what can be modified — diet, activity, microbiome, sleep, stress. We cannot change our genes, but we can change the environment those genes are operating in.

Are there other examples of “disease genes” that were once advantageous?

Yes — haemochromatosis (iron overload) may have protected against bacterial infection; depression-linked genetic variants show advantages in immune response; ADHD-related dopamine variants are adaptive in high-stimulation environments.

What does this mean for genetic testing and disease risk?

Genetic risk is always expressed in an environmental context. Knowing you carry a “risk gene” is most useful as a guide to which environmental factors to prioritise — not as a deterministic sentence.

Understanding the why behind your health history changes what you can do about it. Book a consultation at OQ →